Ataciguat
- Generic Name
- Ataciguat
- Drug Type
- Small Molecule
- Chemical Formula
- C21H19Cl2N3O6S3
- CAS Number
- 254877-67-3
- Unique Ingredient Identifier
- QP166M390Q
- Background
Ataciguat has been investigated for the basic science of Aortic Valve Stenosis.
Ataciguat Shows Promise in Slowing Aortic Valve Stenosis Progression, Mayo Clinic Study Reveals
• A groundbreaking study at Mayo Clinic demonstrates that ataciguat reduced aortic valve calcification progression by 69.8% over six months compared to placebo in patients with moderate aortic valve stenosis.
• The novel drug shows potential to delay or prevent valve replacement surgery, particularly benefiting younger patients who might otherwise need multiple surgeries throughout their lifetime.
• Clinical trials confirm ataciguat's safety profile with minimal side effects, maintaining bone health while effectively slowing valve calcification, paving the way for upcoming Phase 3 trials.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath